Minnesota State College Southeast - News, Events, and Updates
DiaSorin S.p.A. (DSRL.F) Company Information - Simply Wall St
DiaSorin announces the launch of a fully automated serology test to detect antibodies against SARS-CoV-
DiaSorin S.p.A. Completes Acquisition of the Focus Diagnostics' Molecular and Immunoassay Product Business from Quest Diagnostics
DiaSorin : Taking on board the near-term difficulties -August 16, 2023 at 05:46 am| MarketScreener
proudtobeDiaSorin | DiaSorin
DiaSorin - The Diagnostic Specialist
Azioni Diasorin: Analisi Tecnica - Borsa Italiana
Medical Countermeasures | USA Public Health Security
Annual Financial Report
Shares in Diasorin surge ahead of coronavirus diagnostic test launch
DiaSorin Completes $1.8bn Acquisition Of Luminex :: Medtech Insight
Italian test maker DiaSorin puts down $1.8B for Luminex in diagnostics tie-up | Fierce Biotech
Italy's DiaSorin sees 60% plunge in COVID-19 revenue next year | Reuters
DiaSorin Inc. | LinkedIn
DiaSorin to Acquire Focus Diagnostics Unit for $300 Million | Clinical Lab Products
Diasorin Launches LIAISON IQ POC Reader with 10-Minute SARS-CoV-2 Antibody Test - COVID-19 - mobile.Labmedica.com
About us | DiaSorin
DiaSorin | LinkedIn
DiaSorin S.p.A. (DIA) Company Information - Simply Wall St
DiaSorin buys out rival diagnostics firm Luminex for $1.8bn
Diasorin, il titolo vola in borsa dopo i conti del primo semestre: utili e ricavi in calo ma sopra le attese - MilanoFinanza News
DIASORIN S.p.A. REPORT ON THE REMUNERATION POLICY AND FEES PAID 2020
Annual Financial Report
Results | DiaSorin
Relazione_CG_Esercizio_31 12 2008_en
COVID-19 | Updates | DiaSorin
DiaSorin's LIAISON® SARS-CoV-2 Diagnostic Solutions | DiaSorin
Meet our People | DiaSorin
DiaSorin | Saluggia
DiaSorin: Overvalued Italian Healthcare Company (OTCMKTS:DSRLF) | Seeking Alpha
DiaSorin's LIAISON® SARS-CoV-2 Diagnostic Solutions | DiaSorin
DiaSorin | Saluggia
DiaSorin warns of lower revenue as COVID-related demand fades, ET HealthWorld
Milan: DiaSorin on the rise - Borsa Italiana
DiaSorin S.p.A. | DiaSorin
Results | DiaSorin
DiaSorin | Saluggia
Homepage - DiaSorin Molecular
Borsa Milano volatile, cede a realizzi dopo rally recente, giu' banche, Diasorin | Reuters
Report on the Remuneration Policy
Italian biotech company DiaSorin says its Covid-19 tests can detect omicron variant
DiaSorin concludes acquisition of Luminex for $1.8bn
DiaSorin, ricavi in calo nel primo semestre. +4% ex Covid
Untitled
Diasorin heads to the US with $1.8bn Luminex deal | Evaluate
Homepage - DiaSorin Molecular
DiaSorin Spa Italy - DiaSorin Molecular
Results | DiaSorin
/cloudfront-us-east-2.images.arcpublishing.com/reuters/34L6IFUZ2JLLDHCVNW34Y664HE.jpg "Italy's DiaSorin sees 60% plunge in COVID-19 revenue next year | Reuters")
Italy's DiaSorin sees 60% plunge in COVID-19 revenue next year | Reuters
Press Release
